Brief: Orexo Q2 EBITDA Loss Widens To SEK 32.5 Mln

Orexo AB

14/07/2022 07:08

July 14 (Reuters) - Orexo AB  ORX.ST :
    * Q2 REVENUES SEK 147.8 MILLION VERSUS SEK 142.8 MILLION
YEAR AGO
    * Q2 EBITDA OF SEK -32.5 M (-41.1)
    * Q2 US PHARMA SEGMENT (ZUBSOLV US) NET REVENUE SEK 139.6 M
(126.0), EBIT SEK 77.2 M (61.6)

Source text for Eikon:  ID:nWkr9TTdMY 
Further company coverage:  ORX.ST 

 (Gdansk Newsroom)
 ((gdansk.newsroom@thomsonreuters.com; +48 58 772 0920;))